5 Biotech Stocks On Deck With The FDA – Benzinga

Some traders like to gamble on big news events that could have a dramatic effect on a particular stock. For example, the release of a company’s earnings report could cause an underlying stock to jump to new highs or drop to significant lows. While this may not interest all investors, it does prove to be a point of intrigue for […]

Biotech Stock News (SRPT) (BMRN) (PBMD) (ISR) | CNA Finance

Sarepta Therapeutics (NASDAQ:SRPT)After the closing bell on May 19, 2015 shares of Sarepta Therapeutics were up as much as 38% in after-hours trading after the company reported that the FDA will allow the company to file a New Drug Application — NDA — for Eteplirsen. This drug Eteplirsen helps patients with Duchenne Muscular Dystrophy — DMD —  to restore dystrophin […]

Sarepta Gets Delayed And The Stock Gets Drilled

View gallery.Biotech stocks can provide enormous gains, but unfortunately, they can take them away just as quickly.All it takes is one FDA approval for a biotech company’s stock to soar, but an FDA setback could also cause that same stock to tank. One biotech stock suffered that outcome Monday morning.Sarepta Therapeutics Inc (NASDAQ: SRPT) provided an update on its discussions […]

Kotal Equities Sanjeev Prasad outlines trading strategy for elections …

It’s election season so trade is likely to turn volatile as market participants weight various political outcomes. As of now, opinion polls predict the BJP-led NDA to emerge victorious in the polls, but equity strategists know that in a country as diverse as India, it’s futile to hazard a definite guess about electoral outcome and bet your money on it. […]